TABLE 2
Hepatic Vmax for Galactose Determined from 18F-FDGal PET/CT
| Patient no. |  (L blood/min/L of liver) |  (mmol galactose/min/L of liver) |
| 1 | 0.014 ± 0.002 | 0.54 ± 0.31 |
| 2 | 0.026 ± 0.001 | 0.69 ± 0.18 |
| 3 | 0.020 ± 0.001 | 0.74 ± 0.24 |
| 4 | 0.022 ± 0.001 | 0.70 ± 0.45 |
| 5 | 0.039 ± 0.003 | 0.96 ± 0.32 |
| 6 | 0.007 ± 0.002 | 0.27 ± 0.15 |
| 7 | 0.007 ± 0.001 | 0.21 ± 0.11 |
| 8 | 0.015 ± 0.001 | 0.47 ± 0.11 |
| 9 | 0.023 ± 0.002 | ND |
| Mean ± SE | 0.019 ± 0.001 | 0.57 ± 0.06† |
| Healthy subjects | ||
| Mean | 0.019 | 1.41 |
| Range | 0.011–0.029 | 1.10–2.11 |
↵† P < 0.0001 when compared with healthy subjects.
= hepatic systemic clearance of 18F-FDGal determined from 18F-FDGal PET/CT with infusion of galactose; = maximum hepatic removal rate of galactose determined from 18F-FDGal PET/CT according to Equation 4; ND = not determined (LC not available; Table 1); mean ± SE = weighted mean ± SE of weighted mean.Individual data are given as mean ± SE of estimate. Data from healthy subjects are from Sørensen et al. (3).
